Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Gynecologic 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Wilms Tumor 8Retinoblastoma 6Medulloblastoma 6Carcinoma, Renal Cell 6Testicular Neoplasms 5Sarcoma 5Neuroblastoma 5Kidney Neoplasms 5Rhabdomyosarcoma 4Hepatoblastoma 4Astrocytoma 4Sarcoma, Ewing 3Rhabdoid Tumor 3Prostatic Neoplasms 3Ovarian Germ Cell Cancer 3Osteosarcoma 3Optic Nerve Glioma 3Neuroectodermal Tumors, Primitive, Peripheral 3Central Nervous System Neoplasms 3Brain Neoplasms 3Teratoma 2Ovarian Neoplasms 2Neoplasms, Germ Cell and Embryonal 2Neoplasms 2Liver Neoplasms 2Familial ependymoma 2Endodermal Sinus Tumor 2Carcinoma, Embryonal 2Uveal Melanoma 1Urinary Bladder Neoplasms 1

Interventions

cixutumumab 1Thiotepa 1Temozolomide 1Peripheral Blood Stem Cell Transplantation 1Melphalan 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Erlotinib Hydrochloride 1Busulfan 1Bone Marrow Transplantation 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroectodermal Tumors × Granulocyte Colony-Stimulating Factor × Genitourinary × Clear all
NCT00003926 2017-11-29

Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors

Masonic Cancer Center, University of Minnesota

Phase 1 Terminated
13 enrolled
CNSGastrointestinalGenitourinaryGynecologicOther solid neoplasmSarcoma

Ovarian Germ Cell Cancer, Astrocytoma, Brain Neoplasms, Chordoma, Ependymoma, Glioma, Kidney Neoplasms, Liver Neoplasms, Medulloblastoma, Wilms Tumor, Neuroblastoma, Ovarian Neoplasms, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Neuroectodermal Tumors, Hepatoblastoma, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡